GlaxoSmithKline commissioned XVIVO to create a mechanism of action animation for Theravance’s new class of antibiotic, Vibativ developed to stop serious MRSA infections in hospital settings. Vibativ works by preventing bacterial ribosomes from making proteins, which replicating bacteria require to effectively build new cell walls. Bacteria will run out of cell wall material in the replication process effectively killing them.

“I reviewed the video this morning and think it looks truly exceptional—I had high expectations to begin with and you have actually exceeded them.”
CEO, Threshold Pharmaceuticals